Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 30;13(17):5169.
doi: 10.3390/jcm13175169.

Evaluation of Five Screening Tools in Detecting Physical Frailty in Cirrhosis and Their Prognostic Role

Affiliations

Evaluation of Five Screening Tools in Detecting Physical Frailty in Cirrhosis and Their Prognostic Role

Eleni Geladari et al. J Clin Med. .

Abstract

Background: Physical frailty (PF) is a syndrome of decreased physical function and reserves, preventing patients from coping with stressful events. PF screening tools in patients with liver cirrhosis (LC) can help evaluate the risk of complications and death. The aim of this study was to assess the performance of five screening tools in detecting PF and their ability to predict 18-month mortality in LC. Methods: The Short Physical Performance Battery (SPPB), Fried frailty phenotype (FFP), Clinical Frailty Scale (CFS) and 6-Minute Walk Test (6MWT) were compared with the Liver Frailty Index (LFI) as the method of reference. Patients with an LFI ≥ 4.5, SPPB ≤ 8, FFP ≥ 3, CFS ≥ 6 points, and those walking <250 m, were considered frail. Results: A total of 109 consecutive patients with stable LC were included [63.3% male, median age 62 years, (IQR 52-70), MELD 9 (7-14.5), 46.8% with decompensated LC (DC)]. PF was present in 23.9%, 27.5%, 41.3%, 13.8%, and 28.4% as assessed by the LFI, SPPB, FFP, CFS, and 6MWT, respectively. Cohen's kappa measurement of agreement of four of the tools with LFI was 0.568, 0.334, 0.439, and 0.502, respectively (p < 0.001 for each). Kaplan-Meier survival curves at 18 months showed higher mortality in frail patients compared to non-frail patients by any method (log rank p < 0.05). In the multivariate models, PF defined by any method emerged as an independent prognostic factor of 18-month mortality after adjustment for age, gender, and MELD-score. Conclusions: Patients characterized as frail by five screening tools were not identical. However, PF defined by either method was proven to be an independent poor prognostic factor for long-term mortality after adjustment for covariates.

Keywords: 6-Minute Walk Test; Clinical Frailty Scale; Cohen’s kappa measurement of agreement; Fried frailty phenotype; Liver Frailty Index; Short Physical Performance Battery; physical frailty; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier survival curves for frail vs. non-frail patients with 5 screening tools for frailty. (A) Liver Frailty Index; (B) Short Physical Performance Battery; (C) Fried frailty phenotype; (D) Clinical Frailty Scale; (E) 6-Minute Walk Test.

Similar articles

Cited by

References

    1. European Association for the Study of the Liver EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J. Hepatol. 2019;70:172–193. doi: 10.1016/j.jhep.2018.06.024. - DOI - PMC - PubMed
    1. Dent E., Morley J.E., Cruz-Jentoft A.J., Woodhouse L., Rodríguez-Mañas L., Fried L.P., Woo J., Aprahamian I., Sanford A., Lundy J., et al. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. J. Nutr. Health Aging. 2019;23:771–787. doi: 10.1007/s12603-019-1273-z. - DOI - PMC - PubMed
    1. Tandon P., Zanetto A., Piano S., Heimbach J.K., Dasarathy S. Liver transplantation in the patient with physical frailty. J. Hepatol. 2023;78:1105–1117. doi: 10.1016/j.jhep.2023.03.025. - DOI - PMC - PubMed
    1. Cruz-Jentoft A.J., Bahat G., Bauer J., Boirie Y., Bruyère O., Cederholm T., Cooper C., Landi F., Rolland Y., Sayer A.A., et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. doi: 10.1093/ageing/afy169. - DOI - PMC - PubMed
    1. Tandon P., Montano-Loza A.J., Lai J.C., Dasarathy S., Merli M. Sarcopenia and frailty in decompensated cirrhosis. J. Hepatol. 2021;75((Suppl. S1)):S147–S162. doi: 10.1016/j.jhep.2021.01.025. - DOI - PMC - PubMed

LinkOut - more resources